Table of Contents Author Guidelines Submit a Manuscript
Mediators of Inflammation
Volume 2016, Article ID 1625149, 15 pages
http://dx.doi.org/10.1155/2016/1625149
Research Article

P-Selectin Targeted Dexamethasone-Loaded Lipid Nanoemulsions: A Novel Therapy to Reduce Vascular Inflammation

1Institute of Cellular Biology and Pathology “Nicolae Simionescu” of the Romanian Academy, Bucharest, Romania
2Faculty of Veterinary Medicine, University of Agronomic Sciences and Veterinary Medicine, Bucharest, Romania
3Faculty of Biotechnologies, University of Agronomic Sciences and Veterinary Medicine, Bucharest, Romania

Received 12 May 2016; Revised 21 July 2016; Accepted 28 July 2016

Academic Editor: Mirella Giovarelli

Copyright © 2016 Viorel Simion et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. P. Cooke, “The endothelium: a new target for therapy,” Vascular Medicine, vol. 5, no. 1, pp. 49–53, 2000. View at Publisher · View at Google Scholar · View at Scopus
  2. I. Manduteanu and M. Simionescu, “Inflammation in atherosclerosis: a cause or a result of vascular disorders?” Journal of Cellular and Molecular Medicine, vol. 16, no. 9, pp. 1978–1990, 2012. View at Publisher · View at Google Scholar · View at Scopus
  3. P. Rajendran, T. Rengarajan, J. Thangavel et al., “The vascular endothelium and human diseases,” International Journal of Biological Sciences, vol. 9, no. 10, pp. 1057–1069, 2013. View at Publisher · View at Google Scholar · View at Scopus
  4. G. A. Koning, R. M. Schiffelers, and G. Storm, “Endothelial cells at inflammatory sites as target for therapeutic intervention,” Endothelium, vol. 9, no. 3, pp. 161–171, 2002. View at Publisher · View at Google Scholar · View at Scopus
  5. J. M. Metselaar and G. Storm, “Liposomes in the treatment of inflammatory disorders,” Expert Opinion on Drug Delivery, vol. 2, no. 3, pp. 465–476, 2005. View at Publisher · View at Google Scholar · View at Scopus
  6. S. Muro and V. R. Muzykantov, “Targeting of antioxidant and anti-thrombotic drugs to endothelial cell adhesion molecules,” Current Pharmaceutical Design, vol. 11, no. 18, pp. 2383–2401, 2005. View at Publisher · View at Google Scholar · View at Scopus
  7. A. D. Blann, S. K. Nadar, and G. Y. H. Lip, “The adhesion molecule P-selectin and cardiovascular disease,” European Heart Journal, vol. 24, no. 24, pp. 2166–2179, 2003. View at Publisher · View at Google Scholar · View at Scopus
  8. R. P. McEver, J. H. Beckstead, K. L. Moore, L. Marshall-Carlson, and D. F. Bainton, “GMP-140, a platelet α-granule membrane protein, is also synthesized by vascular endothelial cells and is localized in Weibel-Palade bodies,” The Journal of Clinical Investigation, vol. 84, no. 1, pp. 92–99, 1989. View at Publisher · View at Google Scholar · View at Scopus
  9. J.-G. Geng, M. P. Bevilacqua, K. L. Moore et al., “Rapid neutrophil adhesion to activated endothelium mediated by GMP-140,” Nature, vol. 343, no. 6260, pp. 757–760, 1990. View at Publisher · View at Google Scholar · View at Scopus
  10. M. Subramaniam, J. A. Koedam, and D. D. Wagner, “Divergent fates of P- and E-selectins after their expression on the plasma membrane,” Molecular Biology of the Cell, vol. 4, no. 8, pp. 791–801, 1993. View at Publisher · View at Google Scholar · View at Scopus
  11. K. S. Straley and S. A. Green, “Rapid transport of internalized P-selectin to late endosomes and the TGN: roles in regulating cell surface expression and recycling to secretory granules,” The Journal of Cell Biology, vol. 151, no. 1, pp. 107–116, 2000. View at Publisher · View at Google Scholar · View at Scopus
  12. K. Wang, Z. Zhou, X. Zhou, K. Tarakji, E. J. Topol, and A. M. Lincoff, “Prevention of intimal hyperplasia with recombinant soluble P-selectin glycoprotein ligand-immunoglobulin in the porcine coronary artery balloon injury model,” Journal of the American College of Cardiology, vol. 38, no. 2, pp. 577–582, 2001. View at Publisher · View at Google Scholar · View at Scopus
  13. Z. Zhou, M. S. Penn, F. Forudi et al., “Administration of recombinant P-selectin glycoprotein ligand Fc fusion protein suppresses inflammation and neointimal formation in Zucker diabetic rat model,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 22, no. 10, pp. 1598–1603, 2002. View at Publisher · View at Google Scholar · View at Scopus
  14. R. M. Nelson, O. Cecconi, W. G. Roberts, A. Aruffo, R. J. Linhardt, and M. P. Bevilacqua, “Heparin oligosaccharides bind L- and P-selectin and inhibit acute inflammation,” Blood, vol. 82, no. 11, pp. 3253–3258, 1993. View at Google Scholar · View at Scopus
  15. M. S. Mulligan, J. C. Paulson, S. De Frees, Z.-L. Zheng, J. B. Lowe, and P. A. Ward, “Protective effects of oligosaccharides in P-selectin-dependent lung injury,” Nature, vol. 364, no. 6433, pp. 149–151, 1993. View at Publisher · View at Google Scholar · View at Scopus
  16. D. Franchimont, E. Louis, W. Dewe et al., “Effects of dexamethasone on the profile of cytokine secretion in human whole blood cell cultures,” Regulatory Peptides, vol. 73, no. 1, pp. 59–65, 1998. View at Publisher · View at Google Scholar · View at Scopus
  17. T. Rhen and J. A. Cidlowski, “Antiinflammatory action of glucocorticoids—new mechanisms for old drugs,” The New England Journal of Medicine, vol. 353, no. 16, pp. 1658–1723, 2005. View at Publisher · View at Google Scholar · View at Scopus
  18. D. Liu, A. Ahmet, L. Ward et al., “A practical guide to the monitoring and management of the complications of systemic corticosteroid therapy,” Allergy, Asthma and Clinical Immunology, vol. 9, no. 1, article 30, 2013. View at Publisher · View at Google Scholar · View at Scopus
  19. A. Gibofsky, “Combination therapy for rheumatoid arthritis in the era of biologicals,” HSS Journal, vol. 2, no. 1, pp. 30–41, 2006. View at Publisher · View at Google Scholar · View at Scopus
  20. S. A. Ásgeirsdóttir, J. A. A. M. Kamps, H. I. Bakker et al., “Site-specific inhibition of glomerulonephritis progression by targeted delivery of dexamethasone to glomerular endothelium,” Molecular Pharmacology, vol. 72, no. 1, pp. 121–131, 2007. View at Publisher · View at Google Scholar
  21. M. C. C. Ferrer, V. V. Shuvaev, B. J. Zern, R. J. Composto, V. R. Muzykantov, and D. M. Eckmann, “ICAM-1 targeted nanogels loaded with dexamethasone alleviate pulmonary inflammation,” PLoS ONE, vol. 9, no. 7, Article ID e102329, 2014. View at Publisher · View at Google Scholar · View at Scopus
  22. G. A. Koning, R. M. Schiffelers, M. H. M. Wauben et al., “Targeting of angiogenic endothelial cells at sites of inflammation by dexamethasone phosphate-containing RGD peptide liposomes inhibits experimental arthritis,” Arthritis and Rheumatism, vol. 54, no. 4, pp. 1198–1208, 2006. View at Publisher · View at Google Scholar · View at Scopus
  23. S. A. Ásgeirsdóttir, P. J. Zwiers, H. W. Morselt et al., “Inhibition of proinflammatory genes in anti-GBM glomerulonephritis by targeted dexamethasone-loaded AbEsel liposomes,” American Journal of Physiology—Renal Physiology, vol. 294, no. 3, pp. F554–F561, 2008. View at Publisher · View at Google Scholar · View at Scopus
  24. T. J. M. Molenaar, J. Twisk, S. A. M. De Haas et al., “P-selectin as a candidate target in atherosclerosis,” Biochemical Pharmacology, vol. 66, no. 5, pp. 859–866, 2003. View at Publisher · View at Google Scholar · View at Scopus
  25. V. Simion, D. Stan, C. A. Constantinescu et al., “Conjugation of curcumin-loaded lipid nanoemulsions with cell-penetrating peptides increases their cellular uptake and enhances the anti-inflammatory effects in endothelial cells,” Journal of Pharmacy and Pharmacology, vol. 68, no. 2, pp. 195–207, 2016. View at Publisher · View at Google Scholar · View at Scopus
  26. F. J. Martin and D. Papahadjopoulos, “Irreversible coupling of immunoglobulin fragments to preformed vesicles. An improved method for liposome targeting,” Journal of Biological Chemistry, vol. 257, no. 1, pp. 286–288, 1982. View at Google Scholar · View at Scopus
  27. J. Chen, W. T. Dai, Z. M. He et al., “Fabrication and evaluation of curcumin-loaded nanoparticles based on solid lipid as a new type of colloidal drug delivery system,” Indian Journal of Pharmaceutical Sciences, vol. 75, no. 2, pp. 178–184, 2013. View at Google Scholar · View at Scopus
  28. M. J. Kang, B. G. Kim, J. Y. Eum et al., “Design of a Pep-1 peptide-modified liposomal nanocarrier system for intracellular drug delivery: conformational characterization and cellular uptake evaluation,” Journal of Drug Targeting, vol. 19, no. 7, pp. 497–505, 2011. View at Publisher · View at Google Scholar · View at Scopus
  29. C. J. S. Edgell, C. C. McDonald, and J. B. Graham, “Permanent cell line expressing human factor VIII-related antigen established by hybridization,” Proceedings of the National Academy of Sciences of the United States of America, vol. 80, no. 12, pp. 3734–3737, 1983. View at Publisher · View at Google Scholar · View at Scopus
  30. M. M. Pirvulescu, A.-M. Gan, D. Stan et al., “Curcumin and a Morus alba extract reduce pro-inflammatory effects of resistin in human endothelial cells,” Phytotherapy Research, vol. 25, no. 12, pp. 1737–1742, 2011. View at Publisher · View at Google Scholar · View at Scopus
  31. R. G. Gerrity, “The role of the monocyte in atherogenesis: I. Transition of blood-borne monocytes into foam cells in fatty lesions,” The American Journal of Pathology, vol. 103, no. 2, pp. 181–190, 1981. View at Google Scholar
  32. W. E. Sanders, R. W. Wilson, C. M. Ballantyne, and A. L. Beaudet, “Molecular cloning and analysis of in vivo expression of murine P-selectin,” Blood, vol. 80, no. 3, pp. 795–800, 1992. View at Google Scholar · View at Scopus
  33. M. Kamochi, F. Kamochi, Y. B. Kim et al., “P-selectin and ICAM-1 mediate endotoxin-induced neutrophil recruitment and injury to the lung and liver,” American Journal of Physiology—Lung Cellular and Molecular Physiology, vol. 277, no. 2, part 1, pp. L310–L319, 1999. View at Google Scholar · View at Scopus
  34. K. Ley, “The role of selectins in inflammation and disease,” Trends in Molecular Medicine, vol. 9, no. 6, pp. 263–268, 2003. View at Publisher · View at Google Scholar · View at Scopus
  35. R. R. Johnson-Tidey, J. L. McGregor, P. R. Taylor, and R. N. Poston, “Increase in the adhesion molecule P-selectin in endothelium overlying atherosclerotic plaques. Coexpression with intercellular adhesion molecule-1,” The American Journal of Pathology, vol. 144, no. 5, pp. 952–961, 1994. View at Google Scholar · View at Scopus
  36. S. Muro, X. Cui, C. Gajewski, J.-C. Murciano, V. R. Muzykantov, and M. Koval, “Slow intracellular trafficking of catalase nanoparticles targeted to ICAM-1 protects endothelial cells from oxidative stress,” American Journal of Physiology—Cell Physiology, vol. 285, no. 5, pp. C1339–C1347, 2003. View at Publisher · View at Google Scholar · View at Scopus
  37. J. Han, V. V. Shuvaev, P. F. Davies, D. M. Eckmann, S. Muro, and V. R. Muzykantov, “Flow shear stress differentially regulates endothelial uptake of nanocarriers targeted to distinct epitopes of PECAM-1,” Journal of Controlled Release, vol. 210, pp. 39–47, 2015. View at Publisher · View at Google Scholar · View at Scopus
  38. J. Han, B. J. Zern, V. V. Shuvaev, P. F. Davies, S. Muro, and V. Muzykantov, “Acute and chronic shear stress differently regulate endothelial internalization of nanocarriers targeted to platelet-endothelial cell adhesion molecule-1,” ACS Nano, vol. 6, no. 10, pp. 8824–8836, 2012. View at Publisher · View at Google Scholar · View at Scopus
  39. A. H. Sprague and R. A. Khalil, “Inflammatory cytokines in vascular dysfunction and vascular disease,” Biochemical Pharmacology, vol. 78, no. 6, pp. 539–552, 2009. View at Publisher · View at Google Scholar · View at Scopus
  40. V. R. Muzykantov, Targeted Delivery of Biotherapeutics to the Pulmonary Endothelium, Pulmonary Endothelium: Function in Health and Disease, John Wiley & Sons, Chichester, UK, 2009.
  41. V. R. Muzykantov, “Targeted drug delivery to endothelial adhesion molecules,” ISRN Vascular Medicine, vol. 2013, Article ID 916254, 27 pages, 2013. View at Publisher · View at Google Scholar
  42. J. R. Ward, L. Bingle, H. M. Judge et al., “Agonists of toll-like receptor (TLR)2 and TLR4 are unable to modulate platelet activation by adenosine diphosphate and platelet activating factor,” Thrombosis and Haemostasis, vol. 94, no. 4, pp. 831–838, 2005. View at Publisher · View at Google Scholar · View at Scopus
  43. R. E. Rumbaut, R. V. Bellera, J. K. Randhawa et al., “Endotoxin enhances microvascular thrombosis in mouse cremaster venules via a TLR4-dependent, neutrophil-independent mechanism,” American Journal of Physiology—Heart and Circulatory Physiology, vol. 290, no. 4, pp. H1671–H1679, 2006. View at Publisher · View at Google Scholar · View at Scopus
  44. G. Andonegui, S. M. Kerfoot, K. McNagny, K. V. J. Ebbert, K. D. Patel, and P. Kubes, “Platelets express functional Toll-like receptor-4,” Blood, vol. 106, no. 7, pp. 2417–2423, 2005. View at Publisher · View at Google Scholar · View at Scopus
  45. P. N. Shashkin, G. T. Brown, A. Ghosh, G. K. Marathe, and T. M. McIntyre, “Lipopolysaccharide is a direct agonist for platelet RNA splicing,” Journal of Immunology, vol. 181, no. 5, pp. 3495–3502, 2008. View at Publisher · View at Google Scholar · View at Scopus
  46. L. Liaudet, K. G. K. Murthy, J. G. Mabley et al., “Comparison of inflammation, organ damage, and oxidant stress induced by Salmonella enterica serovar muenchen flagellin and serovar enteritidis lipopolysaccharide,” Infection and Immunity, vol. 70, no. 1, pp. 192–198, 2002. View at Publisher · View at Google Scholar · View at Scopus
  47. E. B. Thorgersen, S. E. Pischke, A. Barratt-Due et al., “Systemic CD14 inhibition attenuates organ inflammation in porcine Escherichia coli sepsis,” Infection and Immunity, vol. 81, no. 9, pp. 3173–3181, 2013. View at Publisher · View at Google Scholar · View at Scopus